The government of El Salvador authorized on Wednesday the import and distribution of vaccine Covid-19 from AstraZeneca , as detailed by the National Drug Directorate (NMD), but without specifying the date of his arrival in the country. The DNM authorized the emergency “special license” for the vaccine, according to a statement.
Earlier this Wednesday, the United Kingdom and Argentina had become the first countries to authorize the AstraZeneca immunizer, making the Central American nation the third to do so. “I believe that the vaccine that AstraZeneca, the University of Oxford, and the Oxford Group for Vaccines develop will be the one that will really make a difference in the pandemic. Why? because they have focused on efficiency, but also on affordable prices, rapid distribution, logistics capabilities and it was designed with the whole world in mind, “said Salvadoran President Nayib Bukele, according to AFP.
At the end of November, Nayib Bukele announced that the government reached an agreement with AstraZeneca for the initial supply of 2 million doses and this Wednesday that immunizer became the first to be approved in this country. The DNM assured that the request and the special license are framed in the provisions of the Drug Law and other instruments such as the Central American Technical Regulation.
In addition, the DNM details that the special license is “technically and legally supported by the evidence generated by the manufacturer and by the health authorities of other countries that have previously issued emergency authorizations for this product.” El Salvador accumulated 45,960 positive cases of the new coronavirus as of Tuesday, with 1,327 deaths.
“This is an important step to defeat Covid-19 and marks the hope to get out of this pandemic,” said the Minister of Health, Francisco Alabí. In Central America, Costa Rica has already started vaccinating citizens with the Pfizer / BioNtech drug. Panama also opted for the same laboratory and is still awaiting the arrival of the doses.